A third of patients with connective tissue disease-associated interstitial lung disease developed progressive pulmonary fibrosis.
Interstitial lung disease (ILD) refers to a group of conditions that cause damage and stiffness in the lung tissue. Over time, this damage can make it harder for oxygen to move into the bloodstream.
The Pulmonary Fibrosis Foundation (PFF) today announced its PFF Walk 2026 schedule as the organization celebrates the 10 (th) season of the national fundraising program, which has raised more than $7.
Common symptoms like shortness of breath or a lingering cough may seem harmless, but when they persist, they could point to ...
There are general risk factors for patients with rheumatic disease developing interstitial lung disease, but there are also disease-specific risk factors depending on which rheumatic disease they have ...
Please provide your email address to receive an email when new articles are posted on . Shortness of breath, male sex, age and elevated inflammatory markers are all ...
Please provide your email address to receive an email when new articles are posted on . “Prior studies in systemic sclerosis (SSc) have not evaluated the relationship between specific bacterial ...
Humanetics Corporation (Humanetics) announced today the launch of a new investigator-initiated clinical trial (IIT) of BIO 300 Oral Suspension (BIO 300), led by Dr. Narek Shaverdian, Director of ...
With a second phase 3 win for Tyvaso in idiopathic pulmonary fibrosis (IPF), United Therapeutics is padding the case for an ...